Jump Financial LLC bought a new stake in Innospec Inc. (NASDAQ:IOSP - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 6,758 shares of the specialty chemicals company's stock, valued at approximately $744,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Murphy & Mullick Capital Management Corp bought a new position in Innospec during the 4th quarter worth about $106,000. Covestor Ltd increased its holdings in Innospec by 13.9% during the 4th quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company's stock worth $106,000 after purchasing an additional 118 shares in the last quarter. Blue Trust Inc. increased its holdings in Innospec by 54.2% during the 4th quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company's stock worth $136,000 after purchasing an additional 422 shares in the last quarter. KBC Group NV increased its holdings in Innospec by 82.3% during the 4th quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company's stock worth $136,000 after purchasing an additional 558 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its holdings in Innospec by 91.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,802 shares of the specialty chemicals company's stock worth $198,000 after purchasing an additional 863 shares in the last quarter. Institutional investors own 96.64% of the company's stock.
Insider Activity at Innospec
In other Innospec news, Director Milton C. Blackmore sold 652 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $67,351.60. Following the transaction, the director now directly owns 8,376 shares of the company's stock, valued at $865,240.80. This represents a 7.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Corbin Barnes sold 2,692 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $278,083.60. Following the completion of the transaction, the senior vice president now directly owns 8,051 shares in the company, valued at approximately $831,668.30. This represents a 25.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,696 shares of company stock worth $794,853. Insiders own 1.31% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on IOSP shares. StockNews.com upgraded Innospec from a "hold" rating to a "buy" rating in a report on Monday. Seaport Res Ptn upgraded shares of Innospec from a "hold" rating to a "strong-buy" rating in a research note on Monday, April 21st.
Check Out Our Latest Analysis on IOSP
Innospec Trading Up 0.0 %
Shares of Innospec stock traded up $0.01 during trading hours on Monday, reaching $89.80. 135,395 shares of the company's stock were exchanged, compared to its average volume of 149,147. The company has a 50 day moving average of $94.36 and a two-hundred day moving average of $106.80. Innospec Inc. has a fifty-two week low of $80.32 and a fifty-two week high of $133.71. The stock has a market cap of $2.26 billion, a P/E ratio of 63.24 and a beta of 1.03.
Innospec (NASDAQ:IOSP - Get Free Report) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.05. Innospec had a net margin of 1.93% and a return on equity of 12.27%. The business had revenue of $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. As a group, analysts expect that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.
Innospec declared that its board has authorized a stock buyback plan on Monday, March 10th that authorizes the company to repurchase $50.00 million in outstanding shares. This repurchase authorization authorizes the specialty chemicals company to repurchase up to 2% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's leadership believes its shares are undervalued.
Innospec Profile
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Read More

Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.